🇩🇪Germany

Fehlentscheidungen durch unvollständiges Tracking

2 verified sources

Definition

Ohne zentrales Tracking-System werden Ressourcen für Submissions investiert, die scheitern, was zu Budgetüberschreitungen führt.

Key Findings

  • Financial Impact: €100.000+ pro fehlgeschlagener Submission (Dossier-Kosten + verzögerte Einnahmen)
  • Frequency: 1-2x pro Jahr pro Pipeline-Produkt
  • Root Cause: Manuelle Excel-Tracking ohne Integration zu CESP/ELSTER

Why This Matters

This pain point represents a significant opportunity for B2B solutions targeting Pharmaceutical Manufacturing.

Affected Stakeholders

C-Level Executives, Portfolio Managers, R&D Directors

Deep Analysis (Premium)

Financial Impact

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Current Workarounds

Financial data and detailed analysis available with full access. Unlock to see exact figures, evidence sources, and actionable insights.

Unlock to reveal

Get Solutions for This Problem

Full report with actionable solutions

$99$39
  • Solutions for this specific pain
  • Solutions for all 15 industry pains
  • Where to find first clients
  • Pricing & launch costs
Get Solutions Report

Methodology & Sources

Data collected via OSINT from regulatory filings, industry audits, and verified case studies.

Evidence Sources:

Related Business Risks

Request Deep Analysis

🇩🇪 Be first to access this market's intelligence